Delivery Order SPE2DB24D3014-SPE2DB24FKRYW
Award Date
8/12/24
Potential Completion Date
8/13/24
Potential Value
$3.4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has a ceiling value of $4,926.66 and an ultimate completion date of January 31, 2022. The contract is a Firm Fixed Price Delivery Order awarded under an Indefinite Delivery Contract (IDC) held by...
This federal contract award is for the delivery of LINZESS 290 MCG CAPSULE UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $10,190.60 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is associated with a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a...
This federal contract award, valued at $1,239.04, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of March 17, 2025. The contract provides for the delivery of LINZESS 72 MCG CAPSULE UU 30S, a pharmaceutical product, to support military healthcare programs. Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide LINZESS 290 MCG CAPSULE UU 30S to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order with a Firm Fixed Price of $1,484.48. The ultimate completion date is July 29, 2024. This appears to be a contract under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 through December 2025 that Amerisourcebergen holds with the DLA Troop...
This federal contract award is for the delivery of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, in the amount of $3,686.07 on October 11, 2024. The contract has an ultimate completion date of October 15, 2024 and is a Delivery Order under a Firm Fixed Price contract type. There is no set-aside designation for this award. As a leading supplier of...
This federal contract award is for the delivery of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $6,997.89, was awarded to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. and the DLA Troop Support Medical, valued at up to $999,999,999.00 and...
This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,222.43, is for the supply of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product. The contract has a firm fixed price pricing type and an ultimate completion date of February 12, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen...
This federal contract award is for the delivery of LINZESS 145 MCG CAPSULE UU 30S, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on February 7, 2024, with a completion date of February 8, 2024. The contract is a Delivery Order with a Firm Fixed Price of $3,220.38. There is no set-aside designation mentioned in the award. Amerisourcebergen Drug Corp holds a $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award ceiling of $1,488.13 and is a delivery order with a firm fixed price. The contract does not have a set-aside designation, indicating open competition. The contract is for the supply of LINZESS 72 MCG CAPSULE UU 30S, a pharmaceutical product. This award is associated with a larger Indefinite...
This federal contract award is for the delivery of LINZESS 145 MCG Capsules to the Defense Logistics Agency (DLA). The $1,621.29 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on December 13, 2022, with a completion date of December 14, 2022. The contract is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026....